Skip to main content
Clinical Trials/JPRN-jRCTc030190277
JPRN-jRCTc030190277
Suspended
Phase 1

Exploratory clinical study to evaluate the safety of Platelet rich plasma transplantation for the periodontal tissue defects - Platelet rich plasma transplantation for the periodontal tissue defects

Tobita Morikuni0 sites2 target enrollmentMarch 31, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Tobita Morikuni
Enrollment
2
Status
Suspended
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tobita Morikuni

Eligibility Criteria

Inclusion Criteria

  • 1\) Have a Periodontal pocket more than 5 mm at baseline examination.
  • 2\) Intrabony defect is 5 mm and more depth, and 2 mm and more width at interproximal site of the experimental tooth by X\-ray examination.
  • 3\) Already have received initial preparation at the screening.
  • 4\) Mobility of experimental tooth is 0, 1, or 2, and exist keratinized gingiva.
  • 5\) Persons whose oral hygiene is established Good oral hygiene.
  • 6\) 20 years and older.
  • 7\) Signed informed consent

Exclusion Criteria

  • 1\) Can not be measured clinical attachment level of experimental tooth.
  • 2\) Have a history of Complicate malignant tumor.
  • 3\) Suspected of oral malignant tumor or precancerous lesion.
  • 4\) Need to undergo the treatment, such as surgical treatment, restorative treatment or root canal treatment, at the experimental tooth within 36 weeks after transplant.
  • 5\) Pregnancy, during breastfeeding, or possibility of pregnancy.
  • 6\) Persons who suffer from disorders of kidney, liver or blood
  • 7\) Have disease of kidney, liver and/or blood.
  • 8\) Have active infectious diseases.
  • 9\) Alcoholism or Drug dependence.
  • 10\) Mental or consciousness disorder.

Outcomes

Primary Outcomes

Not specified

Similar Trials